Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer

Recently, the National Surgical Adjuvant Study of Colorectal Cancer in Japan, a randomised controlled trial of oral uracil–tegafur (UFT) adjuvant therapy for stage III rectal cancer, showed remarkable survival gains, compared with surgery alone. To evaluate value for money of adjuvant UFT therapy, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hisashige, A, Yoshida, S, Kodaira, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570527/
https://www.ncbi.nlm.nih.gov/pubmed/18797469
http://dx.doi.org/10.1038/sj.bjc.6604666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570527/
https://www.ncbi.nlm.nih.gov/pubmed/18797469
http://dx.doi.org/10.1038/sj.bjc.6604666

Ejemplares similares